MedTrace Logo

Optimising the Duration of Cooling in Mild Encephalopathy

NCT03409770 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2023-08-04

No results posted yet for this study

Summary

Phase II randomised control trial of whole body cooling in mild neonatal encephalopathy.

Conditions

  • Neonatal Encephalopathy
  • Hypothermia Neonatal
  • Magnetic Resonance Spectroscopy

Interventions

OTHER

Therapeutic hypothermia

Whole body cooling using a servo controlled device

Sponsors & Collaborators

  • Wayne State University

    collaborator OTHER

  • Thayyil, Sudhin

    lead INDIV

Principal Investigators

  • Sudhin Thayyil, PhD · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
6 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-10
Primary Completion
2024-06-30
Completion
2024-08-30

Countries

  • United States
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409770 on ClinicalTrials.gov